Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitoxantrone in secondary progressive multiple sclerosis
NCT00146159Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Mar 2005
- Primary completion
- Sep 2007
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of mitoxantrone in secondary-progressive multiple sclerosis (SPMS), sponsored by Pfizer. Started Mar 2005; status: terminated.
02
Drugs
mitoxantrone
03
Conditions
secondary-progressive multiple sclerosis (SPMS)
Beyond the preview
Go deeper on NCT00146159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00146159.